BioInvent And ThromboGenics Announce A Strategic Alliance With Roche For TB-403, A Novel Anti-Cancer Antibody

BioInvent International AB (STO:BINV) and ThromboGenics NV (Euronext Brussels: THR) announce that they have entered into a license agreement with Roche (SWX: ROG) for their jointly developed anti-cancer agent TB-403. TB-403 is a novel monoclonal antibody which blocks Placental Growth Factor (PIGF), one of the growth factors responsible for the development of new blood vessels. Under the terms of the agreement effective from June 17, 2008 (or if a U.S.

More: continued here

Filed under: Cancer on June 19th, 2008

Comments are closed.

« Gardeners: Be Cautious Of These Fungal Spores Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related To Treatment Of Symptoms Of Vulvovaginal Atrophy »

Order Cheap Pills - Buy Drugs: Order Cheap Pills from online pharmacy.
Pharmacy Brand Name - Buy Brandname Drugs: Depending on your prescription needs, your savings could be significant if you order online.
Pills Source - Buy Drugs: Pill source
Pills 2 Me - Order RX Pills for You: Just select the medicines you need, fill in our medical questionnaire, and submit your order.
Privacy rx pills - : Get Privacy rx pills
Rx pharma online - : Rx pharma online
Rx Pills for You - : Rx Pills for You
The world pharmacy - : The world pharmacy
Latest News...